Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidyl-prolyl cis-trans isomerase FKBP5 (FKBP51) is an immunophilin protein that functions as a key co-chaperone for heat shock protein 90 (Hsp90) and plays a critical role in regulating the sensitivity of steroid hormone receptors, particularly the glucocorticoid receptor (GR). Under physiological conditions, FKBP51 binds to the GR-Hsp90 complex, sequestering the receptor in the cytoplasm and reducing its affinity for glucocorticoids, thereby acting as a negative regulator of the hypothalamic-pituitary-adrenal (HPA) axis. Epigenetic modifications, genetic polymorphisms (such as rs1360780), and overexpression of FKBP5 are strongly associated with stress-related psychiatric disorders, including major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and anxiety, as well as chronic pain, metabolic dysfunction, and various cancers. Pharmacological targeting of FKBP51 has emerged as a promising therapeutic strategy, with selective small-molecule inhibitors like SAFit1 and SAFit2 demonstrating efficacy in preclinical models by restoring GR sensitivity, promoting autophagy, and alleviating chronic pain and depressive behaviors. However, drug development faces significant challenges, particularly the need to achieve high selectivity over its highly homologous counterplayer FKBP52, which exerts opposing stimulatory effects on GR activity.
Peptidyl-prolyl cis-trans isomerase inhibition, disruption of the Hsp90 co-chaperone complex, and modulation of glucocorticoid receptor sensitivity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase FKBP5 (FKBP51) (FKBP5).